Aphria (APHA) Stock Price, News & Analysis

Company Overview

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Key Stats

• Today's Range: C$16.41 to C$17.52
• 50-Day Range: C$16.55 to C$16.55
• 52-Week Range: C$3.93 to C$40.93
• Volume: 9.61 million shs
• Average Volume: 6.16 million shs
• Market Capitalization: C$5.24 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

APHA Stock Analysis - Frequently Asked Questions

How have APHA shares performed this year?

Aphria's stock was trading at C$16.55 on January 1st, 2024. Since then, APHA shares have increased by 0.0% and is now trading at C$16.55.
View the best growth stocks for 2024 here.

How do I buy shares of Aphria?

Shares of APHA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Canopy Growth (CGC), Aurora Cannabis (ACB), Organigram (OGI), NVIDIA (NVDA) and KushCo (KSHB).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:APHA
• CUSIP: N/A
• CIK: N/A
• Web: www.aphria.com
• Phone: 844-427-4742
• Fax: N/A
• Employees: 1,200
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 59.29
• Current Ratio: 3.37
• Quick Ratio: 1.63

Sales & Book Value

• Annual Sales: C$611.06 million
• Price / Sales: 8.58
• Cash Flow: C$0.74 per share
• Price / Cash Flow: 22.40
• Book Value: C$4.76 per share
• Price / Book: 3.48

Miscellaneous

• Outstanding Shares: 316,795,000
• Free Float: N/A
• Market Cap: C$5.24 billion
• Optionable: Not Optionable
• Beta: N/A